Oracle Unveils Oracle® Health Sciences Cloud

OracleOracle announced that its portfolio of Oracle Health Sciences Cloud Applications will be powered by the next-generation Oracle® Health Sciences Cloud, a scalable and secure software-as-a-service delivery platform tailored for the specific requirements and regulations of the health sciences market.

The enhanced Oracle Health Sciences Cloud delivers life sciences and healthcare applications with unparalleled performance, scalability and security. It supports the increasingly networked environment for research, clinical development, and healthcare delivery wherein data must be effectively and securely managed across multiple organizations, including life sciences companies, contract research organizations (CROs), academic medical centers, and regulators and outsourcing vendors.

In conjunction with Oracle Health Sciences Cloud Applications, Oracle Health Sciences Cloud will help health sciences organizations further accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern. Oracle Health Sciences Cloud is developed and rigorously tested for the specific security and privacy requirements of the health sciences industry. This HIPAA certified cloud provides full qualification and validation testing for each instance of the deployed application and is compliant with U.S. Food & Drug Administration (FDA) 21 CFR Part 11.

Oracle Health Sciences solutions currently available as a service on the Oracle Health Sciences Cloud include electronic data capture, electronic patient reported outcomes, study design, coding and dictionary management, trial randomization and drug supply management, research clinic automation, as well as safety management and will expand over time. The Oracle Health Sciences Cloud currently hosts over 3,800 application instances supporting hundreds of thousands of users and millions of transactions per day in more than 117 countries.

The new Oracle Health Sciences Cloud will take advantage of Oracle’s hardware and software, including Oracle Fusion Middleware, Oracle Exadata Database Machine, and Oracle’s Sun ZFS Storage Appliance.

"Delivering cloud applications that support the stringent regulatory environment and networked nature of clinical trials requires not only technical expertise, but significant industry expertise, as well," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Oracle Health Sciences Cloud and our proven portfolio of Oracle Health Sciences Cloud Applications offer customers a formidable combination of scalability, data security, value, and confidence."

Related news articles:

About Oracle
Oracle is the world's most complete, open, and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...